id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0719-0010,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2020-05-21T04:00:00Z,2020,5,2020-05-21T04:00:00Z,,2020-05-21T13:03:58Z,2020-10977,0,0,090000648465d77c
FDA-2013-N-0719-0009,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Planning for the
Effects of High Absenteeism To Ensure Availability of Medically
Necessary Drug Products",Notice,30 Day Proposed Information Collection,2020-02-03T05:00:00Z,2020,2,2020-02-03T05:00:00Z,2020-03-05T04:59:59Z,2020-02-03T15:14:10Z,2020-01992,0,0,0900006484320785
FDA-2013-N-0719-0008,FDA,FDA-2013-N-0719,Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products,Other,Guidance,2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2024-11-12T23:15:15Z,,1,0,090000648425e08e
FDA-2013-N-0719-0007,FDA,FDA-2013-N-0719,Agency Information Collection Activities; Proposed Collection; Comment Request; Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products,Notice,60 Day Proposed Information Collection,2019-10-25T04:00:00Z,2019,10,2019-10-25T04:00:00Z,2019-12-25T04:59:59Z,2019-10-25T13:34:29Z,2019-23272,0,0,09000064840f8d16
FDA-2013-N-0719-0006,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2017-07-03T04:00:00Z,2017,7,2017-07-03T04:00:00Z,,2017-07-03T15:54:12Z,2017-13890,0,0,09000064827dee90
FDA-2013-N-0719-0004,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Planning for the Effects of High Absenteeism To Ensure
Availability of Medically Necessary Drug Products",Notice,30 Day Proposed Information Collection,2017-03-15T04:00:00Z,2017,3,2017-03-15T04:00:00Z,2017-04-15T03:59:59Z,2017-03-16T01:02:31Z,2017-05100,0,0,0900006482508929
FDA-2013-N-0719-0003,FDA,FDA-2013-N-0719,Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products,Notice,60 Day Proposed Information Collection,2016-11-03T04:00:00Z,2016,11,2016-11-03T04:00:00Z,2017-01-04T04:59:59Z,2016-11-03T12:56:36Z,2016-26527,0,0,090000648236d90b
FDA-2013-N-0719-0002,FDA,FDA-2013-N-0719,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products,Notice,30 Day Proposed Information Collection,2013-12-02T05:00:00Z,2013,12,2013-12-02T05:00:00Z,2014-01-03T04:59:59Z,2013-12-03T01:11:39Z,2013-28735,0,0,09000064814a2106
FDA-2013-N-0719-0001,FDA,FDA-2013-N-0719,Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products,Notice,60 Day Proposed Information Collection,2013-06-21T04:00:00Z,2013,6,2013-06-21T04:00:00Z,2013-08-21T03:59:59Z,2013-12-03T03:04:24Z,2013-14812,0,0,09000064813375bd